SCHEMBL3635110

SCHEMBL3635110

CCS(=O)(=O)NC(=O)C1CCN(c2ccc(C(N)=O)cc2)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 1/20 0.49
CHRNA10 Q9GZZ6 1/20 0.49
CHRNA9 Q9UGM1 1/20 0.49
GPR119 Q8TDV5 1/20 0.48
ADRB2 P07550 1/20 0.43
ADRB1 P08588 1/20 0.43
ADRB3 P13945 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.42
USP2 O75604 2/20 0.42
ME3 Q16798 1/20 0.41
LMNA P02545 2/20 0.41
GAA P10253 1/20 0.41
KDM4E B2RXH2 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
HSD17B10 Q99714 1/20 0.41
HRH3 Q9Y5N1 1/20 0.41
ITGB3 P05106 1/20 0.40
ITGA2B P08514 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3816065 0.87 GFER (0.44) KMT2AUSP2ME3LMNAGAA
SCHEMBL3633174 0.87 GPR119 (0.50) CHRNA7CHRNA10CHRNA9GPR119ADRB2
SCHEMBL3637762 0.84 GPR119 (0.53) CHRNA7CHRNA10CHRNA9GPR119ADRB2
SCHEMBL27712656 0.75 NOTUM (0.54) CHRNA7CHRNA10CHRNA9GPR119USP2
SCHEMBL3815470 0.74 GFER (0.47) GPR119MEN1KMT2AME3LMNA
SCHEMBL16130769 0.73 USP2 (0.73) CHRNA7CHRNA10CHRNA9GPR119MEN1
SCHEMBL28184738 0.73 SMN1; SMN2 (0.48) CHRNA7CHRNA10CHRNA9MEN1KMT2A
SCHEMBL4990283 0.73 CHRNA7 (0.58) CHRNA7CHRNA10CHRNA9GPR119MEN1
SCHEMBL3631885 0.73 GPR119 (0.53) CHRNA7CHRNA10CHRNA9GPR119ADRB2
SCHEMBL18871943 0.72 GPR119 (0.55) CHRNA7CHRNA10CHRNA9GPR119MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2155687-A1 DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS Via Pharmaceuticals, Inc. (US) 2010-02-24 EP disclosed
US-20090170864-A1 Diacylglycerol Acyltransferase Inhibitors MADRIGAL PHARMACEUTICALS, INC. 2009-07-02 US disclosed
US-20090105273-A1 Diacylglycerol Acyltransferase Inhibitors MADRIGAL PHARMACEUTICALS, INC. 2009-04-23 US disclosed
US-20090099201-A1 Diacylglycerol Acyltransferase Inhibitors VIA PHARMACEUTICALS, INC. 2009-04-16 US disclosed
US-20090093497-A1 Diacylglycerol Acyltransferase Inhibitors MADRIGAL PHARMACEUTICALS, INC. 2009-04-09 US disclosed
WO-2008141976-A1 DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS VIA PHARMACEUTICALS, INC. (US) 2008-11-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090093497-A1 Diacylglycerol Acyltransferase Inhibitors DGAT2, DGAT1, LCAT CHRNA7 4349/4885CHRNA10 4368/4885CHRNA9 4295/4885
US-20090170864-A1 Diacylglycerol Acyltransferase Inhibitors DGAT2, DGAT1, LCAT CHRNA7 4349/4885CHRNA10 4368/4885CHRNA9 4295/4885
US-20090099201-A1 Diacylglycerol Acyltransferase Inhibitors DGAT2, DGAT1, LCAT CHRNA7 4349/4885CHRNA10 4368/4885CHRNA9 4295/4885
US-20090105273-A1 Diacylglycerol Acyltransferase Inhibitors DGAT2, DGAT1, LCAT CHRNA7 4349/4885CHRNA10 4368/4885CHRNA9 4295/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.